Package 55319-624-12

{"route": ["ORAL"], "spl_id": "43f5b769-711e-58cf-e063-6394a90a5674", "openfda": {"unii": ["H0G9379FGK", "NBZ3QY004S"], "rxcui": ["237865"], "spl_set_id": ["5e996df3-25a4-b259-e053-2a91aa0a4311"], "manufacturer_name": ["FAMILY DOLLAR SERVICES INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "355 mL in 1 BOTTLE (55319-624-12)", "package_ndc": "55319-624-12", "marketing_start_date": "20170801"}], "brand_name": "SUPREME ANTACID", "product_id": "55319-624_43f5b769-711e-58cf-e063-6394a90a5674", "dosage_form": "SUSPENSION", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "55319-624", "generic_name": "calcium carbonate, magnesium hydroxide", "labeler_name": "FAMILY DOLLAR SERVICES INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "SUPREME ANTACID", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "400 mg/5mL"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "135 mg/5mL"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20170601", "listing_expiration_date": "20261231"}